Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Debt Ratio: 2022-2025

Historic Debt Ratio for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Sep 2025 value amounting to 0.86.

  • Phathom Pharmaceuticals' Debt Ratio rose 89.82% to 0.86 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.86, marking a year-over-year increase of 89.82%. This contributed to the annual value of 0.53 for FY2024, which is 59.84% up from last year.
  • Phathom Pharmaceuticals' Debt Ratio amounted to 0.86 in Q3 2025, which was up 5.12% from 0.82 recorded in Q2 2025.
  • Phathom Pharmaceuticals' Debt Ratio's 5-year high stood at 0.86 during Q3 2025, with a 5-year trough of 0.33 in Q4 2023.
  • Moreover, its 3-year median value for Debt Ratio was 0.53 (2024), whereas its average is 0.56.
  • In the last 5 years, Phathom Pharmaceuticals' Debt Ratio crashed by 42.38% in 2023 and then skyrocketed by 89.82% in 2025.
  • Over the past 4 years, Phathom Pharmaceuticals' Debt Ratio (Quarterly) stood at 0.58 in 2022, then plummeted by 42.38% to 0.33 in 2023, then skyrocketed by 59.84% to 0.53 in 2024, then surged by 89.82% to 0.86 in 2025.
  • Its last three reported values are 0.86 in Q3 2025, 0.82 for Q2 2025, and 0.69 during Q1 2025.